We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ICL:TASEICL Group Ltd. Analysis

Data as of 2026-06-16 - not real-time

$5.42

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ICL has posted a solid start to 2026, with revenue up ~14% YoY to $2 bn and net income of $126 m, prompting an upgraded EBITDA outlook and a higher quarterly dividend. The stock trades at a forward PE of ~12x versus a trailing PE of ~26x, a price‑to‑book of 1.16 and a dividend yield of 3.3%, while analysts see ~19% upside to the consensus target of $6.45. Technically, the 20‑day SMA (≈6.10) sits above the 50‑day SMA (≈5.83) and the 200‑day SMA (≈5.70), indicating a bullish longer‑term framework, but the price (≈$5.42) is below all three averages, RSI is near 35 (potentially oversold) and MACD is bearish, suggesting short‑term pressure. Volume is increasing, beta is sub‑1 (≈0.85) and 30‑day volatility is high (~49%), reflecting a volatile but fundamentally resilient position. The company’s high payout ratio (~86%) and modest free cash flow raise questions about dividend sustainability, while a new $800 m senior note at 6% adds leverage to an already elevated debt‑to‑equity profile.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI and price below key SMAs suggest near‑term bounce
  • Increasing volume supports short‑term buying pressure
  • Analyst upside potential of ~19% to $6.45

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of ~14% and upgraded EBITDA guidance
  • Attractive forward PE (~12x) versus peers
  • Dividend increase and strong dividend yield

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio and large new senior‑note issuance
  • Elevated payout ratio may pressure cash flow sustainability
  • Fundamental exposure to cyclical basic‑materials markets

Key Metrics & Analysis

Financial Health

Revenue Growth14.50%
Profit Margin3.52%
P/E Ratio25.8
ROE5.04%
ROA3.82%
Debt/Equity49.80
P/B Ratio1.2
Op. Cash Flow$1.1B
Free Cash Flow$55.4M

Technical Analysis

TrendBullish
RSI35.2
Support$5.41
Resistance$6.78
MA 20$6.10
MA 50$5.83
MA 200$5.70
MACDBearish
VolumeIncreasing
Fear & Greed Index92.79

Valuation

Target Price$6.45
Upside/Downside19.00%
GradeUndervalued
TypeBlend
Dividend Yield3.31%

Risk Assessment

Beta0.85
Volatility49.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.